MoneyWorks4Me

Sigachi Industries informs about statement of deviation

14 Feb 2023 Evaluate
Pursuant to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sigachi Industries has informed that it enclosed statement of deviation(s) or variation(s) in utilization of funds raised through Initial Public Offering (IPO) for the quarter ended December 31, 2022, in the prescribed format. The Company has confirmed that there has been no deviation in the utilization of proceeds of IPO as mentioned in the objects stated in the Prospectus dated November 08, 2021. Monitoring agency report issued in this regard is being separately filed with the exchange.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..